Manipulative therapies for infantile colic

Dawn Dobson1, Peter L B J Lucassen, Joyce J Miller

  • 1Complementary and Integrated Medicine Research Unit, Department of Primary Care, University of Southampton, Southampton,UK. d dobson is@hotmail.co.uk.

Insights

Manipulative therapies may reduce crying time in infants with colic, but study limitations prevent definitive conclusions on effectiveness or safety. More rigorous research is needed to confirm benefits and ensure infant well-being.

Area of Science:

  • Pediatrics
  • Complementary and Alternative Medicine
  • Evidence-Based Practice

Background:

  • Infantile colic affects approximately 16% of families, incurring significant healthcare costs and potential long-term sequelae for infants and parents.
  • Manipulative therapies, including chiropractic and osteopathy, are proposed interventions for reducing infantile colic symptoms.

Purpose of the Study:

  • To evaluate the efficacy and effectiveness of manipulative therapies (chiropractic, osteopathy, cranial manipulation) for infantile colic in infants under six months.
  • To synthesize evidence from randomized controlled trials on manipulative therapies for infant colic.

Main Methods:

  • Comprehensive database searches were conducted across multiple scientific and clinical trial registries.
  • Randomized trials comparing manipulative therapies (alone or combined) against controls for infantile colic were included.
  • Study eligibility, data extraction, and risk of bias assessments were performed independently by multiple reviewers.

Main Results:

  • Five of six included studies suggested a beneficial effect of manipulative therapies on infantile colic.
  • Meta-analysis indicated a statistically significant reduction in daily crying time (1 hour 12 minutes) with manipulative therapies.
  • Clinical significance was suggested by a higher proportion of parents reporting improvement, but results were not significant when controlling for performance bias.

Conclusions:

  • Small study size and methodological biases (particularly performance bias) limit definitive conclusions on the effectiveness of manipulative therapies for infantile colic.
  • While some studies suggest reduced crying and clinically significant improvements, the lack of blinding in most trials necessitates further high-quality research.
  • Insufficient data exists to draw firm conclusions regarding the safety of manipulative therapies for infantile colic.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...